Your browser doesn't support javascript.
loading
Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients.
Lang, Claudia C V; Renert-Yuval, Yael; Del Duca, Ester; Pavel, Ana B; Wu, Jianni; Zhang, Ning; Dubin, Celina; Obi, Ashley; Chowdhoury, Mashkura; Kim, Madeline; Estrada, Yeriel D; Krueger, James G; Kaderbhai, Hashim; Semango, George; Schmid-Grendelmeier, Peter; Brüggen, Marie-Charlotte; Masenga, John E; Guttman-Yassky, Emma.
Afiliação
  • Lang CCV; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
  • Renert-Yuval Y; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
  • Del Duca E; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Dermatology, University of Magna Graecia, Catanzaro, Italy.
  • Pavel AB; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Biomedical Engineering, University of Mississippi, Oxford, Mississippi.
  • Wu J; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Zhang N; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Dubin C; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Obi A; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Chowdhoury M; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kim M; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Estrada YD; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Krueger JG; Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
  • Kaderbhai H; Department of Dermatology, M.P. Shah Hospital, Nairobi, Kenya; Department of Dermatology, Regional Dermatology Training Center, Moshi, Tanzania.
  • Semango G; Department of Dermatology, Regional Dermatology Training Center, Moshi, Tanzania.
  • Schmid-Grendelmeier P; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
  • Brüggen MC; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland; Hochgebirgsklinik Davos, Davos, Switzerland.
  • Masenga JE; Department of Dermatology, Regional Dermatology Training Center, Moshi, Tanzania.
  • Guttman-Yassky E; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Emma.Guttman@mountsinai.org.
Ann Allergy Asthma Immunol ; 127(3): 334-341, 2021 09.
Article em En | MEDLINE | ID: mdl-33975024
ABSTRACT

BACKGROUND:

Atopic dermatitis (AD) is a common disease, with particularly high prevalence found in Africa. It is increasingly recognized that patients with AD of different ethnic backgrounds have unique molecular signatures in the skin, potentially accounting for treatment response variations. Nevertheless, the skin profile of patients with AD from Africa is unknown, hindering development of new treatments targeted to this patient population.

OBJECTIVE:

To characterize the skin profile of patients with AD from Africa.

METHODS:

Gene expression studies, including RNA sequencing (using threshold of fold change of >2 and false discovery rate of <0.05) and real-time polymerase chain reaction, were performed on skin biopsies of Tanzanian patients with moderate-to-severe AD and controls.

RESULTS:

Tanzanian AD skin presented robust up-regulations of multiple key mediators of both T helper 2 (TH2) (interleukin 13 [IL-13], IL-10, IL-4R, CCL13,CCL17,CCL18,CCL26) and TH22 (IL22, S100As) pathways. Markers related to TH17 and IL-23 (IL-17A, IL-23A, IL-12, PI3, DEFB4B) and TH1 (interferon gamma, CXCL9,CXCL10,CXCL11) were also significantly overexpressed in AD tissues (FDR<.05), albeit to a lesser extent. IL-36 isoforms revealed substantial up-regulations in African skin. The barrier fingerprint of Tanzanian AD revealed no suppression of hallmark epidermal barrier differentiation genes, such as filaggrin, loricrin, and periplakin, with robust attenuation of lipid metabolism genes (ie, AWAT1).

CONCLUSION:

The skin phenotype of Tanzanian patients with AD is consistent with that of African Americans, exhibiting dominant TH2 and TH22 skewing, minimal dysregulation of terminal differentiation, and even broader attenuation of lipid metabolism-related products. These data highlight the unique characteristic of AD in Black individuals and the need to develop unique treatments targeting patients with AD from these underrepresented populations.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Dermatite Atópica País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Dermatite Atópica País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça